Literature DB >> 18497029

Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards.

Patrick Salaun1, Yoann Rannou, Claude Prigent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497029      PMCID: PMC2533106          DOI: 10.1007/978-0-387-69080-3_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  113 in total

Review 1.  Cell cycle control as a basis for cancer drug development (Review).

Authors:  E R McDonald; W S El-Deiry
Journal:  Int J Oncol       Date:  2000-05       Impact factor: 5.650

Review 2.  Phosphorylation of serine 10 in histone H3, what for?

Authors:  Claude Prigent; Stefan Dimitrov
Journal:  J Cell Sci       Date:  2003-09-15       Impact factor: 5.285

3.  A small C-terminal sequence of Aurora B is responsible for localization and function.

Authors:  Laetitia Scrittori; Dimitrios A Skoufias; Fabienne Hans; Véronique Gerson; Paolo Sassone-Corsi; Stefan Dimitrov; Robert L Margolis
Journal:  Mol Biol Cell       Date:  2004-10-27       Impact factor: 4.138

4.  Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins.

Authors:  A Karaiskou; L H Perez; I Ferby; R Ozon; C Jessus; A R Nebreda
Journal:  J Biol Chem       Date:  2001-07-18       Impact factor: 5.157

Review 5.  Polo-like kinases and oncogenesis.

Authors:  Frank Eckerdt; Juping Yuan; Klaus Strebhardt
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

6.  Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease.

Authors:  Lucas Kneisel; Klaus Strebhardt; August Bernd; Manfred Wolter; Angelika Binder; Roland Kaufmann
Journal:  J Cutan Pathol       Date:  2002-07       Impact factor: 1.587

Review 7.  Never say never. The NIMA-related protein kinases in mitotic control.

Authors:  Matthew J O'Connell; Michael J E Krien; Tony Hunter
Journal:  Trends Cell Biol       Date:  2003-05       Impact factor: 20.808

8.  Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues.

Authors:  Salvatore Ulisse; Jean-Guy Delcros; Enke Baldini; Matteo Toller; Francesco Curcio; Laura Giacomelli; Claude Prigent; Francesco S Ambesi-Impiombato; Massimino D'Armiento; Yannick Arlot-Bonnemains
Journal:  Int J Cancer       Date:  2006-07-15       Impact factor: 7.396

9.  Drosophila aurora B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis.

Authors:  R Giet; D M Glover
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

10.  Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis.

Authors:  Rüdiger Neef; Christian Preisinger; Josephine Sutcliffe; Robert Kopajtich; Erich A Nigg; Thomas U Mayer; Francis A Barr
Journal:  J Cell Biol       Date:  2003-08-25       Impact factor: 10.539

View more
  25 in total

1.  Misshapen-like kinase 1 (MINK1) is a novel component of striatin-interacting phosphatase and kinase (STRIPAK) and is required for the completion of cytokinesis.

Authors:  Toshinori Hyodo; Satoko Ito; Hitoki Hasegawa; Eri Asano; Masao Maeda; Takeshi Urano; Masahide Takahashi; Michinari Hamaguchi; Takeshi Senga
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Mitotic-dependent phosphorylation of leukemia-associated RhoGEF (LARG) by Cdk1.

Authors:  Michelle C Helms; Elda Grabocka; Matthew K Martz; Christopher C Fischer; Nobuchika Suzuki; Philip B Wedegaertner
Journal:  Cell Signal       Date:  2015-10-19       Impact factor: 4.315

3.  9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema.

Authors:  Inho Choi; Sunju Lee; Hee Kyoung Chung; Yong Suk Lee; Kyu Eui Kim; Dongwon Choi; Eun Kyung Park; Dongyun Yang; Tatiana Ecoiffier; John Monahan; Wen Chen; Berenice Aguilar; Ha Neul Lee; Jaehyuk Yoo; Chester J Koh; Lu Chen; Alex K Wong; Young-Kwon Hong
Journal:  Circulation       Date:  2012-01-24       Impact factor: 29.690

4.  Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.

Authors:  Arminja N Kettenbach; Devin K Schweppe; Brendan K Faherty; Dov Pechenick; Alexandre A Pletnev; Scott A Gerber
Journal:  Sci Signal       Date:  2011-06-28       Impact factor: 8.192

5.  Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer.

Authors:  Yun Feng; Hongliang Liu; Bensong Duan; Zhensheng Liu; James Abbruzzese; Kyle M Walsh; Xuefeng Zhang; Qingyi Wei
Journal:  Carcinogenesis       Date:  2019-06-10       Impact factor: 4.944

6.  Nek9 regulates spindle organization and cell cycle progression during mouse oocyte meiosis and its location in early embryo mitosis.

Authors:  Shang-Wu Yang; Chen Gao; Lei Chen; Ya-Li Song; Jin-Liang Zhu; Shu-Tao Qi; Zong-Zhe Jiang; Zhong-Wei Wang; Fei Lin; Hao Huang; Fu-Qi Xing; Qing-Yuan Sun
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

7.  Splice Modulation Synergizes Cell Cycle Inhibition.

Authors:  Kelsey A Trieger; James J La Clair; Michael D Burkart
Journal:  ACS Chem Biol       Date:  2020-02-17       Impact factor: 5.100

Review 8.  Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.

Authors:  Katalin Hegyi; Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2012-07-29       Impact factor: 3.201

9.  Identification of Candidate Cyclin-dependent kinase 1 (Cdk1) Substrates in Mitosis by Quantitative Phosphoproteomics.

Authors:  Adam Petrone; Mark E Adamo; Chao Cheng; Arminja N Kettenbach
Journal:  Mol Cell Proteomics       Date:  2016-05-01       Impact factor: 5.911

10.  Evidence that human blastomere cleavage is under unique cell cycle control.

Authors:  Ann A Kiessling; Ritsa Bletsa; Bryan Desmarais; Christina Mara; Kostas Kallianidis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2009-03-14       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.